Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).
<h4>Background</h4>National Institute of Mental Health Project Accept (HIV Prevention Trials Network [HPTN] 043) is a large, Phase III, community-randomized, HIV prevention trial conducted in 48 matched communities in Africa and Thailand. The study intervention included enhanced communit...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fe8f9227f4ab405085832b59c3b4eef8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fe8f9227f4ab405085832b59c3b4eef8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fe8f9227f4ab405085832b59c3b4eef82021-11-18T07:37:50ZEstimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).1932-620310.1371/journal.pone.0068349https://doaj.org/article/fe8f9227f4ab405085832b59c3b4eef82013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874597/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>National Institute of Mental Health Project Accept (HIV Prevention Trials Network [HPTN] 043) is a large, Phase III, community-randomized, HIV prevention trial conducted in 48 matched communities in Africa and Thailand. The study intervention included enhanced community-based voluntary counseling and testing. The primary endpoint was HIV incidence, assessed in a single, cross-sectional, post-intervention survey of >50,000 participants.<h4>Methods</h4>HIV rapid tests were performed in-country. HIV status was confirmed at a central laboratory in the United States. HIV incidence was estimated using a multi-assay algorithm (MAA) that included the BED capture immunoassay, an avidity assay, CD4 cell count, and HIV viral load.<h4>Results</h4>Data from Thailand was not used in the endpoint analysis because HIV prevalence was low. Overall, 7,361 HIV infections were identified (4 acute, 3 early, and 7,354 established infections). Samples from established infections were analyzed using the MAA; 467 MAA positive samples were identified; 29 of those samples were excluded because they contained antiretroviral drugs. HIV prevalence was 16.5% (range at study sites: 5.93% to 30.8%). HIV incidence was 1.60% (range at study sites: 0.78% to 3.90%).<h4>Conclusions</h4>In this community-randomized trial, a MAA was used to estimate HIV incidence in a single, cross-sectional post-intervention survey. Results from this analysis were subsequently used to compare HIV incidence in the control and intervention communities.<h4>Trial registration</h4>ClinicalTrials.gov NCT00203749.Oliver LaeyendeckerEstelle Piwowar-ManningAgnes FiammaMichal KulichDeborah DonnellDeb BassukCaroline E MullisCraig ChinPriscilla SwansonJohn HackettWilliam ClarkeMark MarzinkeGreg SzekeresGlenda GrayLinda RichterMichel W AlexandreSuwat ChariyalertsakAlfred ChingonoDavid D CelentanoStephen F MorinMichael SweatThomas CoatesSusan H EshlemanPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e68349 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Oliver Laeyendecker Estelle Piwowar-Manning Agnes Fiamma Michal Kulich Deborah Donnell Deb Bassuk Caroline E Mullis Craig Chin Priscilla Swanson John Hackett William Clarke Mark Marzinke Greg Szekeres Glenda Gray Linda Richter Michel W Alexandre Suwat Chariyalertsak Alfred Chingono David D Celentano Stephen F Morin Michael Sweat Thomas Coates Susan H Eshleman Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). |
description |
<h4>Background</h4>National Institute of Mental Health Project Accept (HIV Prevention Trials Network [HPTN] 043) is a large, Phase III, community-randomized, HIV prevention trial conducted in 48 matched communities in Africa and Thailand. The study intervention included enhanced community-based voluntary counseling and testing. The primary endpoint was HIV incidence, assessed in a single, cross-sectional, post-intervention survey of >50,000 participants.<h4>Methods</h4>HIV rapid tests were performed in-country. HIV status was confirmed at a central laboratory in the United States. HIV incidence was estimated using a multi-assay algorithm (MAA) that included the BED capture immunoassay, an avidity assay, CD4 cell count, and HIV viral load.<h4>Results</h4>Data from Thailand was not used in the endpoint analysis because HIV prevalence was low. Overall, 7,361 HIV infections were identified (4 acute, 3 early, and 7,354 established infections). Samples from established infections were analyzed using the MAA; 467 MAA positive samples were identified; 29 of those samples were excluded because they contained antiretroviral drugs. HIV prevalence was 16.5% (range at study sites: 5.93% to 30.8%). HIV incidence was 1.60% (range at study sites: 0.78% to 3.90%).<h4>Conclusions</h4>In this community-randomized trial, a MAA was used to estimate HIV incidence in a single, cross-sectional post-intervention survey. Results from this analysis were subsequently used to compare HIV incidence in the control and intervention communities.<h4>Trial registration</h4>ClinicalTrials.gov NCT00203749. |
format |
article |
author |
Oliver Laeyendecker Estelle Piwowar-Manning Agnes Fiamma Michal Kulich Deborah Donnell Deb Bassuk Caroline E Mullis Craig Chin Priscilla Swanson John Hackett William Clarke Mark Marzinke Greg Szekeres Glenda Gray Linda Richter Michel W Alexandre Suwat Chariyalertsak Alfred Chingono David D Celentano Stephen F Morin Michael Sweat Thomas Coates Susan H Eshleman |
author_facet |
Oliver Laeyendecker Estelle Piwowar-Manning Agnes Fiamma Michal Kulich Deborah Donnell Deb Bassuk Caroline E Mullis Craig Chin Priscilla Swanson John Hackett William Clarke Mark Marzinke Greg Szekeres Glenda Gray Linda Richter Michel W Alexandre Suwat Chariyalertsak Alfred Chingono David D Celentano Stephen F Morin Michael Sweat Thomas Coates Susan H Eshleman |
author_sort |
Oliver Laeyendecker |
title |
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). |
title_short |
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). |
title_full |
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). |
title_fullStr |
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). |
title_full_unstemmed |
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). |
title_sort |
estimation of hiv incidence in a large, community-based, randomized clinical trial: nimh project accept (hiv prevention trials network 043). |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/fe8f9227f4ab405085832b59c3b4eef8 |
work_keys_str_mv |
AT oliverlaeyendecker estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT estellepiwowarmanning estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT agnesfiamma estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT michalkulich estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT deborahdonnell estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT debbassuk estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT carolineemullis estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT craigchin estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT priscillaswanson estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT johnhackett estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT williamclarke estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT markmarzinke estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT gregszekeres estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT glendagray estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT lindarichter estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT michelwalexandre estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT suwatchariyalertsak estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT alfredchingono estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT daviddcelentano estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT stephenfmorin estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT michaelsweat estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT thomascoates estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 AT susanheshleman estimationofhivincidenceinalargecommunitybasedrandomizedclinicaltrialnimhprojectaccepthivpreventiontrialsnetwork043 |
_version_ |
1718423201267056640 |